Renovaro Biosciences
Price & Volume
Stats
See more52W Range | $1.20-$21 |
Market Cap | $33.8M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$10.80 |
News
See moreYahoo Finance • 9 days ago
Lunai Bioworks to effect 10:1 reverse stock split
Yahoo Finance • last month
PREDICTIVE ONCOLOGY INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI
Yahoo Finance • 4 months ago
Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform
About
CEO | Mr. David H. Weinstein |
Address | 2080 Century Park East, Los Angeles, CA, United States, 90067 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 25 |
